Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.130
+0.100 (3.30%)
At close: Apr 28, 2026, 4:00 PM EDT
3.070
-0.060 (-1.92%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Xenetic Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 2.98 | 2.5 | 2.54 | 1.71 | 1.16 | |
| Revenue Growth (YoY) | 19.04% | -1.56% | 48.80% | 47.06% | 165.64% | |
| Gross Profit | 2.98 | 2.5 | 2.54 | 1.71 | 1.16 | |
| Selling, General & Admin | 2.75 | 3.42 | 3.56 | 3.65 | 3.74 | |
| Research & Development | 3.07 | 3.29 | 3.49 | 4.77 | 3.16 | |
| Operating Expenses | 5.81 | 6.7 | 7.06 | 8.42 | 6.91 | |
| Operating Income | -2.83 | -4.2 | -4.52 | -6.72 | -5.75 | |
| Interest & Investment Income | 0.15 | 0.25 | 0.36 | 0.17 | 0.1 | |
| Other Non Operating Income (Expenses) | 0.01 | -0.01 | 0.03 | -0 | 0 | |
| EBT Excluding Unusual Items | -2.68 | -3.96 | -4.13 | -6.55 | -5.65 | |
| Pretax Income | -2.68 | -3.96 | -4.13 | -6.55 | -5.65 | |
| Net Income | -2.68 | -3.96 | -4.13 | -6.55 | -5.65 | |
| Net Income to Common | -2.68 | -3.96 | -4.13 | -6.55 | -5.65 | |
| Shares Outstanding (Basic) | 2 | 2 | 2 | 1 | 1 | |
| Shares Outstanding (Diluted) | 2 | 2 | 2 | 1 | 1 | |
| Shares Change (YoY) | 10.40% | 0.86% | 7.44% | 38.38% | 60.81% | |
| EPS (Basic) | -1.58 | -2.57 | -2.71 | -4.61 | -5.49 | |
| EPS (Diluted) | -1.58 | -2.57 | -2.71 | -4.61 | -5.49 | |
| Free Cash Flow | -2.29 | -2.82 | -4.11 | -4.65 | -4.74 | |
| Free Cash Flow Per Share | -1.34 | -1.83 | -2.69 | -3.27 | -4.61 | |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -95.23% | -168.16% | -177.78% | -393.57% | -495.12% | |
| Profit Margin | -90.07% | -158.39% | -162.78% | -383.87% | -486.36% | |
| Free Cash Flow Margin | -76.83% | -112.69% | -161.98% | -272.23% | -408.21% | |
| EBITDA | - | - | - | - | -5.75 | |
| D&A For EBITDA | - | - | - | - | 0 | |
| EBIT | -2.83 | -4.2 | -4.52 | -6.72 | -5.75 | |
| EBIT Margin | -95.23% | -168.16% | -177.78% | - | - | |
| Revenue as Reported | 2.98 | 2.5 | 2.54 | 1.71 | 1.16 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.